Laurie Baylor Curtis
About Laurie Baylor Curtis
Laurie Baylor Curtis serves as the Vice President and Head of Global Clinical Operations at Sangamo Therapeutics, Inc., bringing extensive experience from various roles in clinical research and operations across notable institutions and companies.
Current Role at Sangamo Therapeutics
Laurie Baylor Curtis serves as the Vice President and Head of Global Clinical Operations at Sangamo Therapeutics, Inc. since 2019. In this role, she oversees the strategic direction and management of clinical operations on a global scale. Her responsibilities include ensuring the successful execution of clinical trials and optimizing operational efficiencies within the organization. She operates from both London, United Kingdom, and San Francisco, California.
Previous Experience at Sangamo Therapeutics
Prior to her current position, Laurie Baylor Curtis worked at Sangamo Therapeutics, Inc. as the European Head of Clinical Operations from 2018 to 2019. In this capacity, she was responsible for managing clinical operations across Europe, focusing on the implementation and oversight of clinical studies within the region.
Work History at Memorial Sloan Kettering Cancer Center
Laurie Baylor Curtis has an extensive history with Memorial Sloan Kettering Cancer Center, where she held multiple roles. She worked as a Clinical Research Nurse II in the Department of Gastrointestinal Oncology from 1997 to 1998, followed by a position as Clinical Research Nurse III in the same department for 11 months in 1998. She later served as Clinical Research Manager in the Clinical Trials Office of the Division of Hematological Oncology from 1998 to 2000.
Education and Expertise
Laurie Baylor Curtis earned a Bachelor of Science in Nursing from the University of Pennsylvania, completing her degree from 1991 to 1995. She furthered her education at Columbia University, where she obtained a Master of Science in Biostatistics from 1998 to 2002. Her educational background supports her expertise in clinical operations and research methodologies.
Experience in Global Clinical Operations
Laurie Baylor Curtis has held various positions in global clinical operations across multiple organizations. She worked at GlaxoSmithKline as Director of Clinical Operations for Emerging Markets R&D from 2010 to 2015, and as Associate Director of Study Management in Oncology R&D from 2006 to 2009. Additionally, she served as Vice President and Head of Clinical Operations at Nordic Nanovector ASA from 2015 to 2018, contributing to her extensive knowledge in the field.